Introduction

Opioids and Death Investigation: A “Perfect Storm”

Opioids and Death Investigation: A “Perfect Storm”

← Back to Series 

Overview

The scope of the opioid epidemic presents unprecedented challenges to the medical examiner and coroner community. This webinar will explore the intersection of the opioid epidemic with the work of America’s medical examiners and coroners.

The opioid epidemic in the US has resulted in historic numbers of drug-related fatalities. The Centers for Disease Control notes that more than six out of ten drug-related fatalities involve an opioid. Since 1999, the number of deaths involving opioids—including prescription opioids and heroin—quadrupled. Some 91 Americans die every day from an opioid overdose. Drug-related fatalities now exceed the peak numbers of other public health scourges such as HIV (1995), motor vehicle accidents (1972), and gun violence (1993).

Medical examiners and coroners (ME/C) are responsible for investigation and certification of all unnatural deaths in their jurisdictions, in accordance with state statute. Such unnatural deaths include apparent drug intoxications. Components of ME/C death investigations include assessment of the scene of death, review of medical records, coordination with law enforcement and first responders, performance of an autopsy, collection of appropriate specimens for toxicological analysis, interpretation of laboratory results, and death certification. This labor-intensive process requires both medicolegal death investigators and forensic pathologists (FPs).

A certificate of completion is available for all who register and attend this webinar.

Presenter

  • Andrew Baker

Funding for this Forensic Technology Center of Excellence webinar has been provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.

The opinions, findings, and conclusions or recommendations expressed in this webinar are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at ForensicCOE@rti.org with any questions and subscribe to our newsletter for notifications.


Related Content

White Paper – Forensic Community Drug Database Conceptualization

Date February 2024 Overview The National Institute of Justice (NIJ)-in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)-convened a virtual Medicolegal Death…

Technical Note – The Use of Neutral Losses and Common Fragments Screening by QTOF in Forensic Laboratories

Date February 2024 Overview Quadrupole time-of-flight (QTOF) mass spectrometry is an advanced analytical technique that has some capabilities that make it particularly useful in screening in toxicology cases for unknown analytes. The technology combines the power of a quadrupole mass…

Drug Surveillance Initiatives: An FTCOE Repository of Resources

Date December 2023 Overview In the realm of drug surveillance, a multitude of data sources originate from diverse funding agencies, including but not limited to the Drug Enforcement Administration (DEA), National Institute on Drug Abuse (NIDA), Centers for Disease Control…